Detailed program planning and rigorous, continuing evaluation has been critical for the development of the research infrastructure at the Hollings Cancer Center (HCC). They are based on multiple feedback mechanisms and both external and internal review. The HCC External Scientific Advisory Board is the primary external mechanism for review and advice on the HCC's progress in research. Internal mechanisms include the advice and counsel of HCC's associate directors who formally comprise the HCC Executive Council;the HCC Research Committee, which combines the leadership of the associate directors and program leaders;an Internal Institutional Advisory Committee that meets annually and includes MUSC leaders and officials;and a Clinical Research Resource Committee encompassing multidisciplinary clinical leadership who are critical to the HCC's clinical research enterprise. Other planning and evaluation efforts occur at the program and shared resource levels and are essential to the strength of the Center. A critical element of the planning process is the written strategic plan. Dr. Kraft and the Center's leadership updated this strategic plan in 2009 to guide the development of the HCC over the current CCSG project period. This plan identified: 1) The need to expand services within existing shared research resources as well as create new shared research resources;2) Organizational strategies to improve collaboration, interdisciplinary interactions, and educational efforts;and 3) Targeted faculty recruitment to expand the depth and breadth of the HCC research base. It also identified nine strategic focus areas for research development. This 2009-2013 strategic plan has regularly been re-visited, reviewed for progress, and updated with the input of the HCC's leadership team. The vast majority of the strategic plan has been accomplished, and an updated 2014-2018 plan is underdevelopment

Public Health Relevance

The ongoing, clearly-defined, formative and summative evaluation and planning processes of the Hollings Cancer Center are key to its unprecedented growth and sustained excellence in performance as indicated by achievement of benchmarks of success in all aspects of its mission.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA138313-06
Application #
8695838
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-04-01
Project End
2019-03-31
Budget Start
2014-06-20
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
$24,762
Indirect Cost
$8,223
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Link, Laura A; Howley, Breege V; Hussey, George S et al. (2016) PCBP1/HNRNP E1 Protects Chromosomal Integrity by Translational Regulation of CDC27. Mol Cancer Res 14:634-46
Nelson, Michelle H; Bowers, Jacob S; Bailey, Stefanie R et al. (2016) Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning. J Immunother Cancer 4:6
Podbielska, Maria; Szulc, Zdzisław M; Kurowska, Ewa et al. (2016) Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line. J Lipid Res 57:2028-2039
Sambandam, Yuvaraj; Sakamuri, Sashank; Balasubramanian, Sundaravadivel et al. (2016) RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells. J Cell Biochem 117:118-25
Miller, Kayla; Dixit, Suraj; Bredlau, Amy-Lee et al. (2016) Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers. Nanomedicine (Lond) 11:581-95
Basher, Fahmin; Jeng, Emily K; Wong, Hing et al. (2016) Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC. Oncotarget 7:814-30
Small, James; Flanagan, Catherine; Armeson, Kent et al. (2016) Family history of cutaneous and noncutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: A case-control study. J Am Acad Dermatol 75:1066-1068.e7
Maldonado, Eduardo N; DeHart, David N; Patnaik, Jyoti et al. (2016) ATP/ADP Turnover and Import of Glycolytic ATP into Mitochondria in Cancer Cells Is Independent of the Adenine Nucleotide Translocator. J Biol Chem 291:19642-50
Hendriks, Giel; Derr, Remco S; Misovic, Branislav et al. (2016) The Extended ToxTracker Assay Discriminates Between Induction of DNA Damage, Oxidative Stress, and Protein Misfolding. Toxicol Sci 150:190-203
Paul, Matt R; Levitt, Nicholas P; Moore, David E et al. (2016) Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA. BMC Genomics 17:263

Showing the most recent 10 out of 311 publications